medigraphic.com
SPANISH

MediSur

ISSN 1727-897X (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 4

<< Back Next >>

Medisur 2014; 12 (4)

Microbiological isolation of Sporothrix Schenckii in an immunocompromised patient. A case report

Pérez ML, Iglesias LM, Quiñones CO, Reyes RI
Full text How to cite this article

Language: Spanish
References: 8
Page: 662-669
PDF size: 382.25 Kb.


Key words:

sporothrix, sporotrichosis, immunocompromised host, microbiology, case reports.

ABSTRACT

Sporotrichosis is a subcutaneous mycosis with a variable course caused by a fungus of the genus Sporothrix. We present the case of 67-year-old white patient of rural origin with a history of myelofibrosis that had evolved for ten years and was treated with thalidomide and prednisone. He was admitted to the University General Hospital of Cienfuegos in August 2013 because of skin lesions on the left cheek, chest and forearms. During his stay in the Hematology ward due to his underlying disease, we consulted with the specialists of the Dermatology Department. Several diagnoses were established and multiple antimicrobial treatments were prescribed. No clinical improvement of the lesions was observed. A mycological study showed the presence of Sporothrix schencckii; hence, the patient underwent treatment for sporotrichosis. Given the rarity of this diagnosis in our institution, we decided to present this case.


REFERENCES

  1. Ramírez-Soto MC, Loayza-Calderón M. Esporotricosis polimórfica, un problema de salud pública que debemos valorar. Acta Méd Peruana [revista en Internet]. 2012 [ cited 23 Feb 2014 ] ; 29 (2): [aprox. 15p]. Available from: http://www.scielo.org.pe/scielo.php?script=sci_se rial&pid=1728-5917&lng=es&nrm=iso.

  2. Sánchez-Alemán MÁ, Araiza J, Bonifaz A. Aislamiento y caracterización de cepas silvestres de Sporotrhix schenkii e investigación de reactores a la esporototicina. Gac Méd Méx [revista en Internet]. 2004 [ cited 14 May 2014 ] ; 140 (5): [aprox. 12p]. Available from: http://www.scielo.org.mx/scielo.php?pid=S0016- 38132004000500005&script=sci_arttext.

  3. Camargo L, Jaramillo V, Morantes L, Serna P, Vázquez EM. Esporotricosis: una enfermedad ocupacional poco conocida. Rev CES Salud Pública. 2012 ; 3 (2): 273-9.

  4. Bonifaz A, Vázquez González D. Diagnosis and Treatment of Lymphocutaneous Sporotrichosis: What Are the Options?. Curr Fungal Infect Rep. 2013 ; 7: 252-9.

  5. Queiroz-Telles F, Nucci M, Colombo A, Tobon A, Restrepo A. Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol. 2011 ; 49 (3): 225-36.

  6. López-Romero E, Reyes-Montes M del R, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JM, Mora-Montes H, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiology. 2011 ; 6 (1): 85-102.

  7. Almeida SR. Therapeutic monoclonal antibody for sporotrichosis. Front Microbiol. 2012 ; 3: 409.

  8. Nassif PW, Granado IR, Ferraz JS, Souza R, Nassif AE. Atypical presentation of cutaneous sporotrichosis in an alcoholic patient. Dermatol Online J. 2012 ; 18 (6): 12.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medisur. 2014;12